Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Y2ZS
|
|||
Drug Name |
PMID27607364-Compound-63
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H20FNO3
|
|||
Canonical SMILES |
C1COC2=C1C=CC=C2CN(C3=CC=CC=C3OC4=CC=CC=C4)C(=O)CF
|
|||
InChI |
1S/C23H20FNO3/c24-15-22(26)25(16-18-8-6-7-17-13-14-27-23(17)18)20-11-4-5-12-21(20)28-19-9-2-1-3-10-19/h1-12H,13-16H2/i24-1
|
|||
InChIKey |
RDJNEDDYELAPBM-MIGPCILRSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Translocator protein (TSPO) | Target Info | Ligand | [1] |
Target's Patent Info | Translocator protein (TSPO) | Target's Patent Info | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
HTLV-I infection |
References | Top | |||
---|---|---|---|---|
REF 1 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).Expert Opin Ther Pat. 2016 Nov;26(11):1325-1351. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.